SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-22-038696
Filing Date
2022-06-22
Accepted
2022-06-22 16:47:17
Documents
2
Period of Report
2022-06-17

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3856
2 POA DOCUMENT poa.txt EX-24 4168
  Complete submission text file 0001209191-22-038696.txt   9530
Mailing Address 395 OYSTER POINT BLVD STE 217 SOUTH SAN FRANCISCO CA 94080-1930
Business Address 395 OYSTER POINT BLVD STE 217 SOUTH SAN FRANCISCO CA 94080-1930 206-913-4300
Day One Biopharmaceuticals, Inc. (Issuer) CIK: 0001845337 (see all company filings)

IRS No.: 832415215 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address 395 OYSTER POINT BLVD, SUITE 217 SOUTH SAN FRANCISCO CA 94080
Business Address
Gladstone Michael (Reporting) CIK: 0001864256 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40431 | Film No.: 221032592